Pricing Log in Create free account

Corvus Pharmaceuticals, Inc. (CRVS) vs MeiraGTx Holdings PLC (MGTX)

Corvus Pharmaceuticals, Inc. and MeiraGTx Holdings PLC are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and MeiraGTx Holdings PLC are of similar size ($818.5M and $817.3M). Corvus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; MeiraGTx Holdings PLC trades at 11.8×. MeiraGTx Holdings PLC has the higher net margin (19.9% vs 0.00%) and the higher return on invested capital (66.6% vs −352.5%). Across the 14 metrics below, MeiraGTx Holdings PLC leads on 11 and Corvus Pharmaceuticals, Inc. on 3.

Valuation

Metric CRVS MGTX Biotechnology median
P/E n/m 11.83 10.60
P/S n/m 2.07 9.40
P/B 4.33 3.81 2.13
Price to free cash flow n/m 81.19 25.18
EV/EBITDA n/m 3.94 0.66
EV/Sales n/m 1.96 9.02
Earnings yield (5.77%) 8.45% (32.88%)
Free cash flow yield (4.63%) 1.23% (23.13%)

Profitability

Metric CRVS MGTX Biotechnology median
Gross margin 0.00% 97.95% 68.51%
Operating margin 0.00% 46.30% 0.00%
Net margin 0.00% 19.87% 0.00%
Free cash flow margin 0.00% 2.55% 0.00%
Return on equity (35.43%) 72.22% (51.96%)
Return on assets (32.93%) 26.54% (46.06%)
Return on invested capital (352.49%) 66.60% 0.00%

Growth

Metric CRVS MGTX Biotechnology median
Revenue growth (TTM) — 948.35% 6.76%
EPS growth (last fiscal year) 48.04% 33.02% 29.88%
Revenue growth, 5-year CAGR — 39.22% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVS MGTX Biotechnology median
Debt to equity 0.00 0.46 0.00
Current ratio 16.16 3.76 4.97
Net debt to EBITDA 1.28 0.18 1.01

Dividend

Metric CRVS MGTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVS MGTX Biotechnology median
Market cap 818.50m 817.32m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack